Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers

Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers

VANCOUVER, BC / ACCESS Newswire / June 13, 2025 / Onco-Innovations Limited (CBOE:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into an agreement with the University of Alberta and Cross Cancer Institute to undertake…

Space is the Perfect Place to Study Cancer and Someday Even Treat It

Space may be the perfect place to study cancer - and someday even treat it," writes Space.com: On Earth, gravity slows the development of cancer because cells normally need to be attached to a surface in order to function and grow. But in space, cancer cell clusters can expand in all directions as bubbles, like budding yeast or grapes, said Shay Soker, chief science program officer at Wake Forest's Institute for Regenerative Medicine. Since bubb…

Breakthrough Brain Cancer Research: Onco-Innovations Takes On Deadly Glioblastoma with Novel PNKP Technology

University of Alberta partnership explores PNKP inhibitor potential for glioblastoma, affecting 200,000 patients yearly. See how this breakthrough could transform treatment.